Ron Wyden

This kind of flagrant abuse, flagrant tax evasion, highlights the point that you and I have been talking about, which is that this ball game is all about going after these wealthy tax cheats.

Democrats are committed to the proposition that it should not cost hundreds of dollars and many more hours of time simply to follow the law and to pay what you owe.

Apparently, if he does not get what he wants, he is willing to let this country go through a catastrophic default.

The numbers paint a clear picture.

Democrats made a big investment in taxpayer service with the Inflation Reduction Act, and it goes without saying that now the American people have a right to know what they got with that investment.

The official estimate says that $540 billion of taxes owed go unpaid each year.

Democrats made a big investment in taxpayer service with the Inflation Reduction Act, and it goes without saying that now the American people have a right to know what they got with that investment.

The numbers paint a clear picture. Last year, the IRS was able to answer 15 percent of the phone calls it got. This year, it was 87 percent.

Democrats are committed to the proposition that it should not cost hundreds of dollars and many more hours of time simply to follow the law and to pay what you owe.

Apparently, if he does not get what he wants, he is willing to let this country go through a catastrophic default.

The Congress ought to take a smarter approach.

The IRA was a critical first step at systemically lowering the prices of prescription drugs for Americans.

In my view, that's a clear example of the perverse incentives PBMs have created that leave so many Americans fed up and outraged at the health-care system in this country.

That means looking at pharmacy benefit manager practices with a thorough eye and taking any legislative steps necessary to ensure taxpayers and patients aren't getting a raw deal.

I'm proud to say that this is a hearing with strong bipartisan interest, and Senator Crapo and I have agreed to take on this issue together.

I am leading a bill with Senator Grassley, the Pharmacy Benefit Manager Transparency Act, which would crack down on PBM's opaque rebate practices.

Your bill with Senator Grassley should make it more difficult for PBMs to hide profits from regulators.

What recommendations do you have for how and where to increase transparency throughout the prescription drug supply chain?

The Pharmacy Benefit Manager Transparency Act of 2023 would make material improvements to the transparency of the U.S. health-care system.

I am working on a bill with Senator Grassley, the Pharmacy Benefit Manager Transparency Act, which would shine a light on bad PBM practices.

I am going to go out and have all these town hall meetings, and I am going to hold that up.

People care a whole lot about this matter of getting mugged at the pharmacy counter.

The average price that PBMs charge Medicare Part D plans for the exact same drug is over $3,000.

That is why I previously cosponsored something called Creating Transparency to Have Drug Rebates Unlocked.

We want to make this a bipartisan effort in this committee.